Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 16Recruiting 8Not yet recruiting 4Withdrawn 3Enrolling by invitation 3Unknown 2Terminated 2Available 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Head & Neck 3Endocrine 1CNS 1

Conditions

Breast Neoplasms 333Neoplasms 221Prostatic Neoplasms 197Carcinoma, Non-Small-Cell Lung 156Lung Neoplasms 135Pancreatic Neoplasms 118Colorectal Neoplasms 103Neoplasm Metastasis 100Carcinoma, Hepatocellular 96Leukemia, Myeloid, Acute 94Multiple Myeloma 91Brain Neoplasms 89Lymphoma 86Head and Neck Neoplasms 76Melanoma 73Ovarian Neoplasms 72Leukemia 71Leukemia, Lymphocytic, Chronic, B-Cell 69Glioblastoma 69Precursor Cell Lymphoblastic Leukemia-Lymphoma 66Colonic Neoplasms 61Recurrence 59Lymphoma, Non-Hodgkin 54Rectal Neoplasms 50Hematologic Neoplasms 50Lymphoma, Follicular 49Glioma 49Squamous Cell Carcinoma of Head and Neck 47Lymphoma, Large B-Cell, Diffuse 47Carcinoma, Renal Cell 47

Interventions

lutetium Lu 177 dotatate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Withdrawn × OTHER × Parathyroid Neoplasms × Clear all
NCT03516747 2022-04-11

Preoperational Fine Needle Aspiration of Pathological Parathyroid Gland

HaEmek Medical Center, Israel

Phase NA Withdrawn
Head & Neck

Hypercalcemia, Parathyroid Neoplasms

NCT04106843 2020-09-07

Radioactive Drug (177Lu-DOTATATE) for the Treatment of Locally Advanced, Metastatic, or Unresectable Rare Endocrine Cancers

M.D. Anderson Cancer Center

Phase 2 Withdrawn
CNSEndocrineHead & Neck

Paraganglioma, Parathyroid Neoplasms, Pheochromocytoma, Pituitary Neoplasms, Carcinoma, Medullary

NCT02381925 2015-09-21

Multicenter Registry Comparing Preoperative Imaging for Primary Hyperparathyroidism

Duke University

Withdrawn
Head & Neck

Parathyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡